Warfarin-Induced Calciphylaxis in a COVID-19 Patient

Calciphylaxis is a rare but highly fatal vascular calcification disorder with a predilection for patients with end stage renal disease (ESRD). The pathogenesis of calciphylaxis is unknown, however, several risk factors have been identified such as hypercalcemia, hyperphosphatemia, hyperparathyroidis...

Descripción completa

Detalles Bibliográficos
Autores principales: Abutaki, Fatima H, Alfaraj, Dunya, Alshahrani, Abdullah, Elsharkawy, Tarek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767840/
https://www.ncbi.nlm.nih.gov/pubmed/33391959
http://dx.doi.org/10.7759/cureus.12249
_version_ 1783629049973702656
author Abutaki, Fatima H
Alfaraj, Dunya
Alshahrani, Abdullah
Elsharkawy, Tarek
author_facet Abutaki, Fatima H
Alfaraj, Dunya
Alshahrani, Abdullah
Elsharkawy, Tarek
author_sort Abutaki, Fatima H
collection PubMed
description Calciphylaxis is a rare but highly fatal vascular calcification disorder with a predilection for patients with end stage renal disease (ESRD). The pathogenesis of calciphylaxis is unknown, however, several risk factors have been identified such as hypercalcemia, hyperphosphatemia, hyperparathyroidism, low serum albumin, and history of warfarin therapy. This article presents a case of calciphylaxis induced by warfarin in a COVID-19 patient.
format Online
Article
Text
id pubmed-7767840
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-77678402020-12-31 Warfarin-Induced Calciphylaxis in a COVID-19 Patient Abutaki, Fatima H Alfaraj, Dunya Alshahrani, Abdullah Elsharkawy, Tarek Cureus Emergency Medicine Calciphylaxis is a rare but highly fatal vascular calcification disorder with a predilection for patients with end stage renal disease (ESRD). The pathogenesis of calciphylaxis is unknown, however, several risk factors have been identified such as hypercalcemia, hyperphosphatemia, hyperparathyroidism, low serum albumin, and history of warfarin therapy. This article presents a case of calciphylaxis induced by warfarin in a COVID-19 patient. Cureus 2020-12-24 /pmc/articles/PMC7767840/ /pubmed/33391959 http://dx.doi.org/10.7759/cureus.12249 Text en Copyright © 2020, Abutaki et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Abutaki, Fatima H
Alfaraj, Dunya
Alshahrani, Abdullah
Elsharkawy, Tarek
Warfarin-Induced Calciphylaxis in a COVID-19 Patient
title Warfarin-Induced Calciphylaxis in a COVID-19 Patient
title_full Warfarin-Induced Calciphylaxis in a COVID-19 Patient
title_fullStr Warfarin-Induced Calciphylaxis in a COVID-19 Patient
title_full_unstemmed Warfarin-Induced Calciphylaxis in a COVID-19 Patient
title_short Warfarin-Induced Calciphylaxis in a COVID-19 Patient
title_sort warfarin-induced calciphylaxis in a covid-19 patient
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767840/
https://www.ncbi.nlm.nih.gov/pubmed/33391959
http://dx.doi.org/10.7759/cureus.12249
work_keys_str_mv AT abutakifatimah warfarininducedcalciphylaxisinacovid19patient
AT alfarajdunya warfarininducedcalciphylaxisinacovid19patient
AT alshahraniabdullah warfarininducedcalciphylaxisinacovid19patient
AT elsharkawytarek warfarininducedcalciphylaxisinacovid19patient

Ejemplares similares